Loading organizations...
§ Private Profile · Watertown, MA, USA
Clinical-stage therapeutics company for localized ENT disease treatment.
Lyra Therapeutics has raised $59.5M across 2 funding rounds.
Lyra Therapeutics has raised $59.5M in total across 2 funding rounds.
Lyra Therapeutics has raised $59.5M across 2 funding rounds. Most recently, it raised $30.0M Series C in January 2020.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 29, 2020 | $30M Series C | Konstantin Poukalov | ArrowMark Partners, Intersouth Partners, North Bridge, Polaris Partners, RA Capital Management, Soleus Capital | Announced |
| Sep 26, 2018 | $29.5M Series B | Michael Altman | ArrowMark Partners, Intersouth Partners, North Bridge, Polaris Partners, RA Capital Management, Soleus Capital | Announced |
Lyra Therapeutics has raised $59.5M in total across 2 funding rounds.
Lyra Therapeutics's investors include Konstantin Poukalov, ArrowMark Partners, Intersouth Partners, North Bridge Venture Partners, Polaris Partners, RA Capital Management, Soleus Capital, Michael Altman.